Course Overview



This course will be held again on
April 28 - May 2, 2019.

Information contained in this site is for the 2017 program.
Information for the 2019 is not yet available.


The Comprehensive Update for Cardiovascular Medicine

Hosted only once every two years, this special program delivers an intensive, comprehensive review of the most important changes in cardiovascular medicine. Cardiologists, internists, vascular specialists, family practitioners, pharmacists, PAs, NPs and other healthcare providers can rely on this program for critical updates and recommendations for incorporating them into your practice.

This program is among the highest rated of Harvard Medical School's CME courses. The education is relevant, practical and can be put to immediate use to ensure your patients receive the highest, most up-to-date quality of care, and achieve the best possible outcomes.

Taught by Harvard Medical School faculty who are distinguished for clinical and teaching excellence, this program is well-suited for cardiovascular medicine specialists as well as generalists and specialists in other fields who care for patients with cardiovascular conditions, including:

  • Atherosclerosis: prevention and inflammation
  • Valvular heart disease
  • Advanced heart failure and cardiomyopathy
  • Atrial fibrillation
  • Ventricular arrhythmias, ICDs and pacemakers
  • Pulmonary embolism and pulmonary hypertension
  • Cardio-oncology
  • Vascular medicine, including peripheral artery disease, hypertension, aortic dissection, and vasculitis

The curriculum also focuses on new findings and advances in areas such as:

  • Stroke prevention and treatment, including management tips for patients with atrial fibrillation
  • Mechanical circulatory support
  • Novel oral anticoagulants and antiplatelet agents
  • Integrated multimodality cardiovascular imaging
  • Management of obstructive sleep apnea and its cardiovascular consequences
  • Late-breaking information regarding cardiovascular benefits and risks of anti-diabetic drugs

2017 updates for diagnoses, treatment, and patient care include:

  • New guidelines and practice recommendations for lipid therapy with PCSK9 inhibitors and advanced heart failure therapy 
  • Approaches to tailoring multimodality cardiovascular imaging to the patient: how to deploy magnetic resonance, coronary CT, nuclear imaging, and echocardiography
  • New findings for how general cardiologists should troubleshoot problems with pacemakers and ICDs
  • New strategies to minimize hospital readmission rates for congestive heart failure
  • When to refer patients for combination therapy of idiopathic pulmonary hypertension and which combinations of drugs are most successful
  • Cardiovascular screening and safety in athletes
  • Cardiovascular management of high-risk pregnancy
  • Advances in amyloidosis diagnosis and treatment
  • Update on pericardial diseases